Michael Thirman, MD
University of Chicago
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Romain GUIEZE
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Alessandra Ferrajoli, M.D.
M.D. Anderson Cancer Center
Shared therapeutic areas:
Danelle F James, M.D.
CLL Research Consortium and University of California San Diego
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Ivana Gojo, MD
Johns Hopkins University
Shared therapeutic areas:
Grygorii Ursol, MD, PhD
Medical and Diagnostic Center of Private Enterprise of Private Manufacturing Company "Acinus"
Shared therapeutic areas:
Nicolaus kroeger, MD
BMT Centre, University Hospital Eppendorf, Hamburg, Germany
Shared therapeutic areas:
Thomas J Kipps, M.D., Ph.D
Director of the CLL Research Consortium and University of California San Diego
Shared therapeutic areas:
Peihua Lu, PhD&MD
Hebei Yanda Ludaopei Hospital
Shared therapeutic areas:
Véronique MINARD, MD
Institut Gustave Roussy, Villejuif, FRANCE
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
All 1 trials loaded